All In Biotech

Drug Trial Radar · NCT04422899

Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration

A Phase I Study of the Safety, Pharmacokinetics, and Duration of Effect of Intravitreally Administered AIV007 Gel Suspension in Subjects With Neovascular Age-Related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Dec 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

3

Actual

Start

Aug 28, 2020

Primary completion

Sep 29, 2021

Study completion Feb 28, 2022

Sponsor

Lead sponsor
AiViva BioPharma, Inc.Industry
Sponsor type
Industry
First posted
Jun 9, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine safety, pharmacokinetics, and duration of effect of intravitreally administered AIV007 gel suspension in subjects with neovascular age-related macular degeneration

Conditions

  • Neovascular Age-related Macular Degeneration

Interventions

  • AIV007Drug

    intravitreal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventsTime frame: approximately 224 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Salehi Retina Institute

    Huntington Beach, California

  • Retina Research Institute of Texas

    Abilene, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.